HealthQuill Articles by: HealthQuill
A group of US professors has developed a method to accurately diagnose and treat traumatic brain injuries, providing more rigorous care and preventing premature discussions about halting life support.
Drugs Health Research

New traumatic brain injury test to help prevent early halt of life support

HQ Team May 21, 2025: A group of US professors has developed a method to accurately diagnose and treat traumatic brain injuries, providing

Read More
Long-standing allies and new contributors have stepped up funding to the cash-strapped World Health Organization with a total of $170 million.
Drugs Health Pharma

Governments, philanthropic partners pledge $170 million to WHO

HQ Team May 21, 2025: Long-standing allies and new contributors have stepped up funding to the cash-strapped World Health Organization with a total

Read More
The Food and Drug Administration has come out with new product-specific guidances for developing generic drugs and generating evidence to support abbreviated new drug application approvals.
Drugs Health Pharma

FDA draws up new product guidance for developing generic drugs

HQ Team May 21, 2025: The Food and Drug Administration has come out with new product-specific guidances for developing generic drugs and generating

Read More
Regeneron Pharmaceuticals, Inc. plans to buy most of the assets of the bankrupt genetics and biotechnology company, 23andMe Holding, for $256 million.
Drugs Medical Pharma

Regeneron to buy bankrupt 23andMe Holding assets for $256 million

HQ Team May 20, 2025: Regeneron Pharmaceuticals, Inc. plans to buy most of the assets of the bankrupt genetics and biotechnology company, 23andMe

Read More
The World Health Organization’s members have approved a resolution for the adoption of a historic global agreement to make the world safer from future pandemics.
Drugs Health Medical

WHO members adopt Pandemic Agreement with 124 voting in favour

HQ Team May 20, 2025: The World Health Organization members have formally adopted the world’s first Pandemic Agreement to make the world safer from

Read More
The UN, facing a funding crisis following global budget cuts, is at risk of eroding its credibility and capacity to fulfil the mandates entrusted to it by its 193 members, delegates heard.
Drugs Health Medical

UN’s funding crisis risks credibility, capacity to meet global mandates

HQ Team May 20, 2025: The UN, facing a funding crisis following global budget cuts, is at risk of eroding its credibility and

Read More
Pfizer Inc. has signed a licensing deal worth about $6 billion with China’s 3SBio to develop, manufacture and commercialise an experimental cancer drug.
Drugs Health Pharma

Pfizer signs $6 billion licensing deal with China’s 3SBio for cancer drug

HQ Team May 20, 2025: Pfizer Inc. has signed a licensing deal worth about $6 billion with China’s 3SBio to develop, manufacture and

Read More
US surgeons have performed the world’s first successful human bladder transplant on a 41-year-old patient who lost most of his bladder during a tumour removal process.
Drugs Health Medical

Surgeons in US perform world’s first human bladder transplant on a man

HQ Team May 19, 2025: US surgeons have performed the world’s first successful human bladder transplant on a 41-year-old patient who lost most

Read More
More than one in four cars sold worldwide is set to be electric this year, as the growth of electric vehicles is on course to exceed 40% in another five years, according to an International Energy Agency report.
Climate Health Research

Adaption of electric vehicles surges globally: One in four cars sold is an EV

HQ Team May 19, 2025: More than one in four cars sold worldwide is set to be electric this year, as the growth

Read More
The UK’s Medicines and Healthcare products Regulatory Agency has approved Janssen-Cilag Limited’s guselkumab (Tremfya) to treat Crohn’s disease and ulcerative colitis.
Drugs Health Pharma

UK clears Janssen-Cilag’s drug for Crohn’s disease, ulcerative colitis

HQ Team May 19, 2025: The UK’s Medicines and Healthcare products Regulatory Agency has approved Janssen-Cilag Limited’s guselkumab (Tremfya) to treat Crohn’s disease

Read More